Lista de obras -

Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region

artículo científico publicado en 2019

Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region

artículo científico publicado en 2018

Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico

artículo científico publicado en 2020

Correction to: Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region

artículo científico publicado en 2018

Corrigendum to "New and Emerging Therapies for Osteoporosis"

artículo científico publicado en 2017

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX ⬇️

artículo científico publicado el 1 de julio de 2012

Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

scientific article published on 24 February 2020

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

artículo científico publicado en 2020

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

scientific article published on 13 May 2019

Hip fracture trends in the United States, 2002 to 2015.

artículo científico publicado en 2017

Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.

artículo científico publicado en 2017

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practi

artículo científico

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

artículo científico publicado en 2005

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

artículo científico publicado en 2018

Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017

scientific article published on 15 February 2020

Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.

artículo científico publicado en 2016

Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis

scientific article published on 22 September 2018

Racial disparities, FRAX, and the care of patients with osteoporosis

scientific article published on 26 September 2020

T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial

artículo científico publicado en 2020

Lista de obras de

Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region

Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region

Core principles for fracture prevention: North American Consensus from the National Osteoporosis Foundation, Osteoporosis Canada, and Academia Nacional de Medicina de Mexico

Correction to: Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region

Corrigendum to "New and Emerging Therapies for Osteoporosis"

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX ⬇️

Estimation of Long-Term Efficacy of Denosumab Treatment in Postmenopausal Women With Osteoporosis: A FRAX- and Virtual Twin-Based Post Hoc Analysis From the FREEDOM and FREEDOM Extension Trials

Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

Hip fracture trends in the United States, 2002 to 2015.

Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations.

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(®). Executive Summary of the 2010 Position Development Conference on Interpretation and use of FRAX® in clinical practi

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

New and emerging concepts in the use of denosumab for the treatment of osteoporosis

Osteoporotic fracture trends in a population of US managed care enrollees from 2007 to 2017

Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.

Proceedings of the 2018 Santa Fe Bone Symposium: Advances in the Management of Osteoporosis

Racial disparities, FRAX, and the care of patients with osteoporosis

T-Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial